{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:37:31Z","timestamp":1793385451397,"version":"4.5.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T00:00:00Z","timestamp":1549497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s11095-019-2582-y","type":"journal-article","created":{"date-parts":[[2019,2,7]],"date-time":"2019-02-07T19:22:08Z","timestamp":1549567328000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Analyzing the Mechanisms Behind Macrolide Antibiotic-Induced Liver Injury Using Quantitative Systems Toxicology Modeling"],"prefix":"10.1007","volume":"36","author":[{"given":"Jeffrey L.","family":"Woodhead","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyunghee","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Oldach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"MacLauchlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhavathi","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott Q.","family":"Siler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett A.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,7]]},"reference":[{"issue":"10","key":"2582_CR1","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1164\/rccm.201402-0385CI","volume":"189","author":"RK Albert","year":"2014","unstructured":"Albert RK, Schuller JL, COPD Clinical Research Network. Macrolide antibiotics and the risk of cardiac arrhythmias. Am J Respir Crit Care Med. 2014;189(10):1173\u201380.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2582_CR2","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11882-013-0416-2","volume":"14","author":"A Cervin","year":"2014","unstructured":"Cervin A, Wallwork B. Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis. Curr Allergy Asthma Rep. 2014;14(3):416.","journal-title":"Curr Allergy Asthma Rep"},{"key":"2582_CR3","unstructured":"Macrolide Antibiotics [Internet]. [cited 2018 Jan 4]. Available from: https:\/\/livertox.nih.gov\/MacrolideAntibiotics.htm . Accessed 27 Mar 2018."},{"issue":"7","key":"2582_CR4","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1093\/jac\/dkr159","volume":"66","author":"RJ Andrade","year":"2011","unstructured":"Andrade RJ, Tulkens PM. Hepatic safety of antibiotics used in primary care. J Antimicrob Chemother. 2011;66(7):1431\u201346.","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2582_CR5","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/hep.22620","volume":"49","author":"AD Brinker","year":"2009","unstructured":"Brinker AD, Wassel RT, Lyndly J, Serrano J, Avigan M, Lee WM, et al. Telithromycin-associated hepatotoxicity: clinical spectrum and causality assessment of 42 cases. Hepatol. 2009;49(1):250\u20137.","journal-title":"Hepatol"},{"issue":"3","key":"2582_CR6","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/157488610791698307","volume":"5","author":"M Robles","year":"2010","unstructured":"Robles M, Toscano E, Cotta J, Lucena MI, Andrade RJ. Antibiotic-induced liver toxicity: mechanisms, clinical features and causality assessment. Curr Drug Saf. 2010;5(3):212\u201322.","journal-title":"Curr Drug Saf"},{"key":"2582_CR7","unstructured":"Telithromycin [Internet]. DrugBank; [cited 2016 Nov 1]. Available from: https:\/\/www.drugbank.ca\/drugs\/DB00976 . Accessed 27 Mar 2018."},{"issue":"8","key":"2582_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1093\/cid\/ciw490","volume":"63","author":"TM File","year":"2016","unstructured":"File TM, Rewerska B, Vucinic-Mihailovic V, Gonong JRV, Das AF, Keedy K, et al. SOLITAIRE-IV: a randomized, double-blind, multicenter study comparing the efficacy and safety of intravenous-to-oral solithromycin to intravenous-to-oral moxifloxacin for treatment of community-acquired bacterial pneumonia. Clin Infect Dis. 2016;63(8):1007\u201316.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"2582_CR9","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/S1473-3099(16)00017-7","volume":"16","author":"CM Barrera","year":"2016","unstructured":"Barrera CM, Mykietiuk A, Metev H, Nitu MF, Karimjee N, Doreski PA, et al. Efficacy and safety of oral solithromycin versus oral moxifloxacin for treatment of community-acquired bacterial pneumonia: a global, double-blind, multicentre, randomised, active-controlled, non-inferiority trial (SOLITAIRE-ORAL). Lancet Infect Dis. 2016;16(4):421\u201330.","journal-title":"Lancet Infect Dis"},{"key":"2582_CR10","unstructured":"Solithromycin Oral Capsule and Injection: Meeting of the Antimicrobial Drugs Advisory Committee [Internet]. 2016 [cited 2018 Jan 4]. Available from: https:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/Anti-InfectiveDrugsAdvisoryCommittee\/UCM527690.pdf . Accessed 18 Apr 2018."},{"key":"2582_CR11","unstructured":"FDA Rejects NDAs for Cempra Bacterial Pneumonia Candidate Solithromycin [Internet]. GEN. [cited 2018 Feb 19]. Available from: https:\/\/www.genengnews.com\/gen-news-highlights\/fda-rejects-ndas-for-cempra-bacterial-pneumonia-candidate-solithromycin\/81253623 . Accessed 18 Apr 2018."},{"key":"2582_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.cotox.2017.07.003","volume":"4","author":"P Bloomingdale","year":"2017","unstructured":"Bloomingdale P, Housand C, Apgar JF, Millard BL, Mager DE, Burke JM, et al. Quantitative systems toxicology. Curr Opin Toxicol. 2017;4:79\u201387.","journal-title":"Curr Opin Toxicol"},{"issue":"5","key":"2582_CR13","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10928-012-9266-0","volume":"39","author":"BA Howell","year":"2012","unstructured":"Howell BA, Yang Y, Kumar R, Woodhead JL, Harrill AH, Clewell HJ 3rd, et al. In vitro to in vivo extrapolation and species response comparisons for drug-induced liver injury (DILI) using DILIsym\u2122: a mechanistic, mathematical model of DILI. J Pharmacokinet Pharmacodyn. 2012;39(5):527\u201341.","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"2582_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/bdd.1878","volume":"35","author":"LKM Shoda","year":"2014","unstructured":"Shoda LKM, Woodhead JL, Siler SQ, Watkins PB, Howell BA. Linking physiology to toxicity using DILIsym(\u00ae) , a mechanistic mathematical model of drug-induced liver injury. Biopharm Drug Dispos. 2014;35(1):33\u201349.","journal-title":"Biopharm Drug Dispos"},{"issue":"1","key":"2582_CR15","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.dmpk.2016.11.008","volume":"32","author":"JL Woodhead","year":"2017","unstructured":"Woodhead JL, Watkins PB, Howell BA, Siler SQ, Shoda LKM. The role of quantitative systems pharmacology modeling in the prediction and explanation of idiosyncratic drug-induced liver injury. Drug Metab Pharmacokinet. 2017;32(1):40\u20135.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"1","key":"2582_CR16","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1093\/toxsci\/kfw193","volume":"155","author":"JL Woodhead","year":"2017","unstructured":"Woodhead JL, Brock WJ, Roth SE, Shoaf SE, Brouwer KLR, Church R, et al. Application of a mechanistic model to evaluate putative mechanisms of tolvaptan drug-induced liver injury and identify patient susceptibility factors. Toxicol Sci. 2017;155(1):61\u201374.","journal-title":"Toxicol Sci"},{"key":"2582_CR17","doi-asserted-by":"publisher","first-page":"240","DOI":"10.3389\/fphar.2014.00240","volume":"5","author":"JL Woodhead","year":"2014","unstructured":"Woodhead JL, Yang K, Siler SQ, Watkins PB, Brouwer KLR, Barton HA, et al. Exploring BSEP inhibition-mediated toxicity with a mechanistic model of drug-induced liver injury. Front Pharmacol. 2014;5:240.","journal-title":"Front Pharmacol"},{"key":"2582_CR18","doi-asserted-by":"publisher","unstructured":"Yang Y, Nadanaciva S, Will Y, Woodhead JL, Howell BA, Watkins PB, et al. MITOsym\u00ae: a mechanistic, Mathematical Model of Hepatocellular Respiration and Bioenergetics. Pharm Res. 2015;32:1975-92. https:\/\/doi.org\/10.1007\/s11095-014-1591-0 .","DOI":"10.1007\/s11095-014-1591-0"},{"issue":"1","key":"2582_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/psp4.12053","volume":"5","author":"DM Longo","year":"2016","unstructured":"Longo DM, Yang Y, Watkins PB, Howell BA, Siler SQ. Elucidating differences in the hepatotoxic potential of tolcapone and entacapone with DILIsym(\u00ae), a mechanistic model of drug-induced liver injury. CPT Pharmacometrics Syst Pharmacol. 2016;5(1):31\u20139.","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"issue":"2","key":"2582_CR20","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1124\/jpet.112.192930","volume":"342","author":"JL Woodhead","year":"2012","unstructured":"Woodhead JL, Howell BA, Yang Y, Harrill AH, Clewell HJ 3rd, Andersen ME, et al. An analysis of N-acetylcysteine treatment for acetaminophen overdose using a systems model of drug-induced liver injury. J Pharmacol Exp Ther. 2012;342(2):529\u201340.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"2582_CR21","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0006-8993(01)01988-6","volume":"894","author":"JW Allen","year":"2001","unstructured":"Allen JW, Shanker G, Aschner M. Methylmercury inhibits the in vitro uptake of the glutathione precursor, cystine, in astrocytes, but not in neurons. Brain Res. 2001;894(1):131\u201340.","journal-title":"Brain Res"},{"issue":"15","key":"2582_CR22","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1016\/j.clinbiochem.2007.06.012","volume":"40","author":"K-T Lee","year":"2007","unstructured":"Lee K-T, Tsai S-M, Wang S-N, Lin S-K, Wu S-H, Chuang S-C, et al. Glutathione status in the blood and tissues of patients with virus-originated hepatocellular carcinoma. Clin Biochem. 2007;40(15):1157\u201362.","journal-title":"Clin Biochem"},{"issue":"Suppl 2","key":"2582_CR23","doi-asserted-by":"crossref","first-page":"SP229","DOI":"10.2131\/jts.34.SP229","volume":"34","author":"H Nagasaka","year":"2009","unstructured":"Nagasaka H, Takayanagi M, Tsukahara H. Children\u2019s toxicology from bench to bed--liver injury (3): oxidative stress and anti-oxidant systems in liver of patients with Wilson disease. J Toxicol Sci. 2009;34(Suppl 2):SP229\u201336.","journal-title":"J Toxicol Sci"},{"issue":"11","key":"2582_CR24","first-page":"1427","volume":"25","author":"Y-H Shon","year":"2002","unstructured":"Shon Y-H, Nam K-S. Protective effect of moutan cortex extract on acetaminophen-induced cytotoxicity in human Chang liver cells. Am J Health Syst Pharm. 2002;25(11):1427\u201331.","journal-title":"Am J Health Syst Pharm"},{"issue":"4","key":"2582_CR25","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/hep.1840380426","volume":"38","author":"M P\u00e9rez-Carreras","year":"2003","unstructured":"P\u00e9rez-Carreras M, Del Hoyo P, Mart\u00edn MA, Rubio JC, Mart\u00edn A, Castellano G, et al. Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatol Baltim Md. 2003;38(4):999\u20131007.","journal-title":"Hepatol Baltim Md"},{"issue":"3","key":"2582_CR26","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1078\/0171-9335-00154","volume":"80","author":"H Bantel","year":"2001","unstructured":"Bantel H, Ruck P, Gregor M, Schulze-Osthoff K. Detection of elevated caspase activation and early apoptosis in liver diseases. Eur J Cell Biol. 2001;80(3):230\u20139.","journal-title":"Eur J Cell Biol"},{"issue":"1","key":"2582_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/hep.21214","volume":"44","author":"Y Meier","year":"2006","unstructured":"Meier Y, Pauli-Magnus C, Zanger UM, Klein K, Schaeffeler E, Nussler AK, et al. Interindividual variability of canalicular ATP-binding-cassette (ABC)-transporter expression in human liver. Hepatol Baltim Md. 2006;44(1):62\u201374.","journal-title":"Hepatol Baltim Md."},{"issue":"1","key":"2582_CR28","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1478-3231.2011.02625.x","volume":"32","author":"GA Bernhardt","year":"2012","unstructured":"Bernhardt GA, Zollner G, Cerwenka H, Kornprat P, Fickert P, Bacher H, et al. Hepatobiliary transporter expression and post-operative jaundice in patients undergoing partial hepatectomy. Liver Int Off J Int Assoc Study Liver. 2012;32(1):119\u201327.","journal-title":"Liver Int Off J Int Assoc Study Liver"},{"issue":"3","key":"2582_CR29","first-page":"453","volume":"44","author":"LMM Vermeer","year":"2016","unstructured":"Vermeer LMM, Isringhausen CD, Ogilvie BW, Buckley DB. Evaluation of ketoconazole and its alternative clinical CYP3A4\/5 inhibitors as inhibitors of drug transporters: the in vitro effects of ketoconazole, ritonavir, clarithromycin, and itraconazole on 13 clinically-relevant drug transporters. Toxicol Sci. 2016;44(3):453\u20139.","journal-title":"Toxicol Sci"},{"issue":"1","key":"2582_CR30","first-page":"216","volume":"136","author":"RE Morgan","year":"2013","unstructured":"Morgan RE, van Staden CJ, Chen Y, Kalyanaraman N, Kalanzi J, Dunn RT, et al. A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development. J Appl Physiol. 2013;136(1):216\u201341.","journal-title":"J Appl Physiol."},{"issue":"4","key":"2582_CR31","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1002\/phar.1367","volume":"34","author":"JA Kaye","year":"2014","unstructured":"Kaye JA, Castellsague J, Bui CL, Calingaert B, McQuay LJ, Riera-Guardia N, et al. Risk of acute liver injury associated with the use of moxifloxacin and other oral antimicrobials: a retrospective, population-based cohort study. Pharmacotherapy. 2014;34(4):336\u201349.","journal-title":"Pharmacotherapy"},{"issue":"7","key":"2582_CR32","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1128\/AAC.36.7.1456","volume":"36","author":"JC Mertens","year":"1992","unstructured":"Mertens JC, van Barneveld PW, Asin HR, Ligtvoet E, Visser MR, Branger T, et al. Double-blind randomized study comparing the efficacies and safeties of a short (3-day) course of azithromycin and a 5-day course of amoxicillin in patients with acute exacerbations of chronic bronchitis. Antimicrob Agents Chemother. 1992;36(7):1456\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"2582_CR33","first-page":"149","volume":"54","author":"M Ga\u0161pari\u0107","year":"2015","unstructured":"Ga\u0161pari\u0107 M, Penezi\u0107 A, Kolumbi\u0107-Lako\u0161 A, Kova\u010di\u0107 D, Kukuruzovi\u0107 MM, Bar\u0161i\u0107 B. Safety and effectiveness of azithromycin in the treatment of lower respiratory infections: an international, multicenter, non-comparative study. Acta Clin Croat. 2015;54(2):149\u201358.","journal-title":"Acta Clin Croat"},{"issue":"10","key":"2582_CR34","doi-asserted-by":"publisher","first-page":"810","DOI":"10.2146\/ajhp080687","volume":"67","author":"AM Lockwood","year":"2010","unstructured":"Lockwood AM, Cole S, Rabinovich M. Azithromycin-induced liver injury. Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm. 2010;67(10):810\u20134.","journal-title":"Am J Health-Syst Pharm AJHP Off J Am Soc Health-Syst Pharm"},{"issue":"2","key":"2582_CR35","first-page":"369","volume":"13","author":"MA Martinez","year":"2015","unstructured":"Martinez MA, Vuppalanchi R, Fontana RJ, Stolz A, Kleiner DE, Hayashi PH, et al. Clinical and histologic features of azithromycin-induced liver injury. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc. 2015;13(2):369\u2013376.e3.","journal-title":"Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc"},{"issue":"12","key":"2582_CR36","doi-asserted-by":"publisher","first-page":"5399","DOI":"10.1128\/AAC.00840-10","volume":"54","author":"D Bertrand","year":"2010","unstructured":"Bertrand D, Bertrand S, Neveu E, Fernandes P. Molecular characterization of off-target activities of telithromycin: a potential role for nicotinic acetylcholine receptors. Antimicrob Agents Chemother. 2010;54(12):5399\u2013402.","journal-title":"Antimicrob Agents Chemother"},{"issue":"6917","key":"2582_CR37","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1038\/nature01321","volume":"420","author":"KJ Tracey","year":"2002","unstructured":"Tracey KJ. The inflammatory reflex. Nature. 2002;420(6917):853\u20139.","journal-title":"Nature"},{"key":"2582_CR38","doi-asserted-by":"crossref","unstructured":"Izumi T, Imai J, Yamamoto J, Kawana Y, Endo A, Sugawara H, et al. Vagus-macrophage-hepatocyte link promotes post-injury liver regeneration and whole-body survival through hepatic FoxM1 activation. Nat Commun [Internet]. 2018 Dec 13 [cited 2018 Dec 27];9. Available from: https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6294142\/ . Accessed 27 Dec 2018.","DOI":"10.1038\/s41467-018-07747-0"},{"key":"2582_CR39","doi-asserted-by":"crossref","unstructured":"Hood DA. Invited Review: contractile activity-induced mitochondrial biogenesis in skeletal muscle. Hepatol. 1985. 2001;90(3):1137\u201357.","DOI":"10.1152\/jappl.2001.90.3.1137"},{"issue":"25","key":"2582_CR40","doi-asserted-by":"publisher","first-page":"22047","DOI":"10.1074\/jbc.M111.240481","volume":"286","author":"TA Than","year":"2011","unstructured":"Than TA, Lou H, Ji C, Win S, Kaplowitz N. Role of cAMP-responsive element-binding protein (CREB)-regulated transcription coactivator 3 (CRTC3) in the initiation of mitochondrial biogenesis and stress response in liver cells. J Biol Chem. 2011;286(25):22047\u201354.","journal-title":"J Biol Chem"},{"issue":"3","key":"2582_CR41","first-page":"351","volume":"36","author":"K Hayasaka","year":"1986","unstructured":"Hayasaka K, Takahashi I, Kobayashi Y, Iinuma K, Narisawa K, Tada K. Effects of valproate on biogenesis and function of liver mitochondria. Hepatol. 1986;36(3):351\u20136.","journal-title":"Hepatol"},{"issue":"1","key":"2582_CR42","first-page":"57","volume":"112","author":"KS Sitarz","year":"2014","unstructured":"Sitarz KS, Elliott HR, Karaman BS, Relton C, Chinnery PF, Horvath R. Valproic acid triggers increased mitochondrial biogenesis in POLG-deficient fibroblasts. Liver Int. 2014;112(1):57\u201363.","journal-title":"Liver Int"},{"issue":"9","key":"2582_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.2165\/00003088-200544090-00003","volume":"44","author":"J Shi","year":"2005","unstructured":"Shi J, Montay G, Bhargava VO. Clinical pharmacokinetics of telithromycin, the first ketolide antibacterial. Clin Pharmacokinet. 2005;44(9):915\u201334.","journal-title":"Clin Pharmacokinet"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2582-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2582-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2582-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,11]],"date-time":"2022-09-11T15:34:18Z","timestamp":1662910458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2582-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,7]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["2582"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2582-y","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,7]]},"assertion":[{"value":"24 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"48"}}